Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms

Maricel Marin-Kuan1, Christophe Cavin, Thierry Delatour

  • 1Nestlé Research Center, Quality and Safety, PO Box 44, Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland. maricel.marin-kuan@rdls.nestle.com

Insights

Ochratoxin A (OTA), a food mycotoxin, may cause cancer through multiple epigenetic mechanisms, not just direct DNA damage. These thresholded effects are crucial for food safety risk assessment.

Area of Science:

  • Food toxicology
  • Molecular toxicology
  • Epigenetics

Background:

  • Ochratoxin A (OTA) is a prevalent mycotoxin found in various food products.
  • Human data on OTA's food safety is limited, necessitating reliance on animal studies.
  • Renal toxicity and carcinogenicity are key concerns for OTA in food safety.

Purpose of the Study:

  • To review the epigenetic mechanisms of Ochratoxin A (OTA).
  • To discuss the toxicological relevance of OTA's epigenetic effects.
  • To improve the use of animal data for OTA risk assessment.

Main Methods:

  • Literature review of epigenetic cellular effects of OTA.
  • Analysis of potential toxicological relevance of these mechanisms.
  • Discussion of OTA's mechanism of action in relation to carcinogenicity.

Main Results:

  • OTA's effects are likely mediated by a network of interacting epigenetic mechanisms.
  • Key mechanisms include protein synthesis inhibition, oxidative stress, and cell signaling pathway activation.
  • These mechanisms are proposed to be responsible for OTA-induced carcinogenicity.

Conclusions:

  • OTA's carcinogenicity is unlikely due to a single mechanism.
  • A combination of epigenetic effects, including protein synthesis inhibition and oxidative stress, contributes to OTA's carcinogenic potential.
  • The proposed epigenetic mechanisms are likely thresholded, impacting food safety risk assessment.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...